Literature DB >> 15530831

25 years since the eradication of smallpox: why poxvirus research is still relevant.

Surendran Mahalingam1, Inger K Damon, Brett A Lidbury.   

Abstract

The World Health Organization (WHO) announced the eradication of smallpox twenty-five years ago this month. This conquest of an infectious disease, which has been the bane of humankind for centuries, still stands as the WHO's greatest achievement. The anniversary of such a scientific and medical landmark provides an appropriate occasion to reflect on this feat and to assess the significance and necessity of the poxvirus research that has followed this.

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15530831     DOI： 10.1016/j.it.2004.10.002

Source DB:  PubMed          Journal:  Trends Immunol        ISSN： 1471-4906            Impact factor:   16.687


  15 in total

1.  5-(Dimethoxymethyl)-2'-deoxyuridine: a novel gem diether nucleoside with anti-orthopoxvirus activity.

Authors:  Xuesen Fan; Xinying Zhang; Longhu Zhou; Kathy A Keith; Earl R Kern; Paul F Torrence
Journal:  J Med Chem       Date:  2006-06-01       Impact factor: 7.446

2.  The poxvirus A35 protein is an immunoregulator.

Authors:  Kristina E Rehm; Gwendolyn J B Jones; Alice A Tripp; Mark W Metcalf; Rachel L Roper
Journal:  J Virol       Date:  2010-01       Impact factor: 5.103

3.  Deletion of the A35 gene from Modified Vaccinia Virus Ankara increases immunogenicity and isotype switching.

Authors:  Kristina E Rehm; Rachel L Roper
Journal:  Vaccine       Date:  2011-02-23       Impact factor: 3.641

4.  B5-deficient vaccinia virus as a vaccine vector for the expression of a foreign antigen in vaccinia immune animals.

Authors:  Kendra M Viner; Natasha Girgis; Heesun Kwak; Stuart N Isaacs
Journal:  Virology       Date:  2006-12-26       Impact factor: 3.616

5.  Vaccinia virus A35R inhibits MHC class II antigen presentation.

Authors:  Kristina E Rehm; Ramsey F Connor; Gwendolyn J B Jones; Kenneth Yimbu; Rachel L Roper
Journal:  Virology       Date:  2009-12-02       Impact factor: 3.616

6.  Vaccinia virus decreases major histocompatibility complex (MHC) class II antigen presentation, T-cell priming, and peptide association with MHC class II.

Authors:  Kristina E Rehm; Ramsey F Connor; Gwendolyn J B Jones; Kenneth Yimbu; Mark D Mannie; Rachel L Roper
Journal:  Immunology       Date:  2009-11       Impact factor: 7.397

7.  Orthopoxvirus genome evolution: the role of gene loss.

Authors:  Robert Curtis Hendrickson; Chunlin Wang; Eneida L Hatcher; Elliot J Lefkowitz
Journal:  Viruses       Date:  2010-09-15       Impact factor: 5.818

8.  Mucosal immunization induces a higher level of lasting neutralizing antibody response in mice by a replication-competent smallpox vaccine: vaccinia Tiantan strain.

Authors:  Bin Lu; Wenbo Yu; Xiaoxing Huang; Haibo Wang; Li Liu; Zhiwei Chen
Journal:  J Biomed Biotechnol       Date:  2011-06-20

9.  Genomic sequence and virulence of clonal isolates of vaccinia virus Tiantan, the Chinese smallpox vaccine strain.

Authors:  Qicheng Zhang; Meijuan Tian; Yi Feng; Kai Zhao; Jing Xu; Ying Liu; Yiming Shao
Journal:  PLoS One       Date:  2013-04-12       Impact factor: 3.240

10.  Transdermal influenza immunization with vaccine-coated microneedle arrays.

Authors:  Dimitrios G Koutsonanos; Maria del Pilar Martin; Vladimir G Zarnitsyn; Sean P Sullivan; Richard W Compans; Mark R Prausnitz; Ioanna Skountzou
Journal:  PLoS One       Date:  2009-03-10       Impact factor: 3.240
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.